Alan B. Sandler

Insider Reports History

Entity
Individual
Location
4560 Jinke Road, Bldg. 1, Fourth Floor, Pudong, Shanghai, China
Signature
/s/ Peter Garcia by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alan B. Sandler:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Zai Lab Ltd Head of Global Dev., Oncology Restricted Share Units 73K $1.91M $26.12 Jun 25, 2022 Direct
ALX ONCOLOGY HOLDINGS INC Director Stock Option (right to buy) 40.4K Aug 5, 2024 Direct
Elevation Oncology, Inc. Director Stock Option (Right to Buy) 35K Jun 13, 2024 Direct
Mirati Therapeutics, Inc. Chief Medical Officer Common Stock 0 $59.02 Jan 23, 2024 Direct
Mirati Therapeutics, Inc. Chief Medical Officer Option to Purchase Common Stock 0 Jan 23, 2024 Direct

Insider Reports Filed by Alan B. Sandler

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALXO ALX ONCOLOGY HOLDINGS INC Aug 5, 2024 1 $0 4 Aug 7, 2024 Director
ALXO ALX ONCOLOGY HOLDINGS INC Aug 5, 2024 0 $0 3 Aug 7, 2024 Director
ELEV Elevation Oncology, Inc. Jun 13, 2024 1 $0 4 Jun 17, 2024 Director
ELEV Elevation Oncology, Inc. Feb 29, 2024 1 $0 4 Mar 4, 2024 Director
ELEV Elevation Oncology, Inc. Feb 29, 2024 0 $0 3 Mar 4, 2024 Director
MRTX Mirati Therapeutics, Inc. Jan 23, 2024 4 $0 4 Jan 23, 2024 Chief Medical Officer
MRTX Mirati Therapeutics, Inc. Dec 29, 2023 1 $1M 4 Jan 3, 2024 Chief Medical Officer
MRTX Mirati Therapeutics, Inc. Aug 9, 2023 1 $825K 4 Aug 10, 2023 Chief Medical Officer
MRTX Mirati Therapeutics, Inc. Nov 7, 2022 2 $0 4 Nov 8, 2022 Chief Medical Officer
MRTX Mirati Therapeutics, Inc. Nov 7, 2022 0 $0 3 Nov 8, 2022 Chief Medical Officer
ZLAB Zai Lab Ltd Jun 25, 2022 1 $0 4 Jun 27, 2022 Head of Global Dev., Oncology
ZLAB Zai Lab Ltd Apr 1, 2022 4 $0 4 Apr 5, 2022 Head of Global Dev., Oncology
ZLAB Zai Lab Ltd Dec 1, 2021 1 -$148K 4 Dec 3, 2021 Head of Global Dev., Oncology